SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy crypto is trending amidst strong community skepticism, as many investors who experienced significant losses with the original Mullen Automotive stock now view the new token on the Solana network as another potential 'scam,' while a smaller group of 'Mullenaires' actively promotes it.

SharonAI Holdings, Inc. is a technology company. It focuses on high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI Holdings (SHAZ) is surging amidst community discussion following the release of an ambitious long-term roadmap outlining significant capacity expansion into 2028, further fueled by its association with the bullish AI sector and a notable photo of its co-founder with NVIDIA's CEO.

Berachain

Berachain (BERA) is heavily discussed as its innovative Proof-of-Liquidity (PoL) model and recent ecosystem upgrades, including new vaults and integrations, fuel optimism for a significant breakout. However, the community remains divided, with strong bullish sentiment clashing with warnings about volatility and concerns over token distribution.

MKS, Inc. provides instruments, systems, subsystems and process control solutions to measure, control, power, monitor, and analyze parameters of manufacturing processes to improve process performance and productivity for its customers. It operates through the following segments: VSD (Vacuum Solutions Division), PSD (Photonics Solutions Division), and MSD (Materials Solutions Division). The VSD segment delivers foundational technology solutions to semiconductor manufacturing, electronics and packaging and specialty industrial applications. The PSD Segment provides a range of instruments, components and subsystems to edge semiconductor manufacturing, electronics and packaging and specialty industrial applications. The MSD segment develops process and manufacturing technologies for advanced surface modification, electroless and electrolytic plating, and surface finishing. The company was founded in 1961 and is headquartered in Andover, MA.

MKS Inc.

MKS Instruments, Inc.

MKS Instruments is trending as investors digest a mixed earnings report, where an EPS miss was overshadowed by strong revenue growth and optimistic guidance, reinforcing its position as a key enabler in the expanding AI and semiconductor capital equipment sector. The community is actively discussing its significant role in data center buildout and next-generation manufacturing, viewing it as an attractive long-term play despite some technical signals suggesting caution and recent convertible note offerings.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is trending due to growing institutional interest, including a Grayscale Trust filing and a major treasury acquisition by SovereignAI, alongside its enhanced cross-chain interoperability via 'Intents' and deepening integration with AI through a partnership with NVIDIA. The community is actively accumulating, viewing NEAR as a leading AI-native blockchain with significant long-term potential amid its recent tokenomics adjustments and utility advancements.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy (SWEAT CRYPTO) is trending with community members debating its potential for a significant price rebound following a period of low valuation. Discussions highlight its move-to-earn utility, where users earn crypto for physical activity, prompting some to consider current prices as a long-term buying opportunity.

Viavi Solutions, Inc. engages in the provision of network test, monitoring, and assurance solutions for communications service providers, enterprises, network equipment manufacturers, government and avionics. It operates through the following segments: Network and Service Enablement, and Optical Security and Performance. The Network and Service Enablement segment provides an integrated portfolio of testing, monitoring, assurance and security solutions to help build, maintain and optimize telecom and datacom networks. The Optical Security and Performance segment leverages its core optical coating technologies and volume manufacturing capability to design, manufacture and sell technologies for the anti-counterfeiting, 3D sensing, government and aerospace, automotive and industrial markets. The company was founded in 1979 and is headquartered in Chandler, AZ.

Viavi Solutions Inc

Viavi Solutions is trending after reporting strong quarterly earnings and providing optimistic guidance, driven by robust demand in AI infrastructure, 5G, and data center markets. The company is seeing positive community sentiment and notable analyst upgrades, reflecting its position as a key infrastructure supplier in the evolving telecom sector.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

Heightened community discussion around recently resurfaced Jeffrey Epstein files, which some claim expose links to Bitcoin's early funding, is driving strong bearish sentiment and calls to short the cryptocurrency via BITI. This narrative fuels widespread speculation that Bitcoin is fundamentally flawed and poised for a significant decline.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is actively discussed as its acquisition of Astria Therapeutics completes, integrating the late-stage HAE therapy navenibart into its pipeline just before upcoming earnings and new clinical data presentations. Community sentiment is mixed, balancing optimism for the strengthened rare disease portfolio against concerns over stock performance, perceived dilution, and significant short interest.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending following robust Phase 2 axSpA clinical trial results for sonelokimab, described by the community as potentially "best-in-class" and generating significant buzz ahead of its Investor Day, amplifying discussions around substantial short interest and potential major acquisition interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jupiter Asset Management Ltd. Sells 116,575 Shares of Catalyst Pharmaceuticals, Inc. $CPRX

Jupiter Asset Management Ltd. decreased its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 22.5% during the third quarter, according to the company in its most recent...

Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by Skandinaviska Enskilda Banken AB publ

Skandinaviska Enskilda Banken AB publ trimmed its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 39.3% during the third quarter, according to its most recent filing...

Aberdeen Group plc Has $12.46 Million Stake in Catalyst Pharmaceuticals, Inc. $CPRX

Aberdeen Group plc lessened its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 8.2% during the third quarter, according to the company in its most recent filing with...

BioCryst Pharmaceuticals (BCRX) Earnings Expected to Grow: Should You Buy?

BioCryst (BCRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Analysts Estimate Catalyst Pharmaceutical (CPRX) to Report a Decline in Earnings: What to Look Out for

Catalyst (CPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Catalyst Pharmaceuticals (CPRX) Expected to Announce Earnings on Wednesday

Catalyst Pharmaceuticals (NASDAQ:CPRX) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...

Public Sector Pension Investment Board Grows Stock Holdings in Catalyst Pharmaceuticals, Inc. $CPRX

Public Sector Pension Investment Board boosted its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 10.8% during the third quarter, according to the company in its...

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates

Karyopharm Therapeutics (KPTI) delivered earnings and revenue surprises of +1.47% and +3.27%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Allianz Asset Management GmbH Cuts Stake in Catalyst Pharmaceuticals, Inc. $CPRX

Allianz Asset Management GmbH cut its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 23.1% in the 3rd quarter, according to its most recent disclosure with the...

Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.34	--	--	N/A
Q3 '25	$0.33	$0.42	26.51%	BEAT
Q2 '25	$0.39	$0.41	4.59%	BEAT
Q1 '25	$0.34	$0.45	32.35%	BEAT
Q4 '24	$0.34	$0.44	29.96%	BEAT

CPRX
Catalyst Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest CPRX News

CPRXCatalyst Pharmaceuticals Inc